Related by context. Frequent words. (Click for all words.) 68 Initiates Phase II 67 Receives Orphan Drug Designation 67 Patient Enrollment 66 ALN TTR 66 Completes Enrollment 65 Announces FDA Clearance 65 Presents Positive 64 Pivotal Study 64 Genasense ® oblimersen 64 Meets Primary Endpoint 64 Pivotal Trial 63 FDA Clears 63 Oncotype DX colon cancer 63 Panzem R 63 Phase III Clinical Trial 63 refractory chronic lymphocytic 63 AEG# 63 Entereg R 63 supplemental biologics 62 Septin 9 62 Lymphoseek ® 62 FDA Accepts 62 Pivotal Phase III 62 NEBIDO R 62 metastatic colorectal 62 Epidermal Growth Factor Receptor 62 FACTIVE R gemifloxacin 61 Study Evaluating 61 phase IIb clinical 61 Phase Ib II 61 optical biosensors 61 IND Investigational New 61 Initiate Phase 61 Pralatrexate 61 Clinical Trial Results 61 Hepatitis C Virus HCV 61 RNAi Therapeutics 61 multi kinase inhibitor 61 Pirfenidone 61 Daclizumab 61 Drug Shows Promise 61 Denufosol 61 Phase Ib IIa 61 Drug Candidate 60 DNA RNA Medicines 60 Sapacitabine 60 BLA submission 60 SUCCEED trial 60 Pivotal Phase 60 Factor VIIa 60 sodium Injection 60 Fast Track Status 60 Phase Ib clinical trials 60 Phase III Trial 60 Marketing Authorization Application 60 MEK inhibitor 60 investigational therapies 60 anticancer compound 60 Orphan Drug status 60 Investigational Device Exemption 60 ThermoDox R 60 VEGFR2 inhibitor 60 Small Molecule 60 Application BLA 60 Application MAA 60 Recombinant Human 59 Ixempra 59 Metastatic Melanoma 59 cervical breast 59 Inc. Nasdaq IMGN 59 See BioWorld Today 59 Phase IIb clinical trials 59 submitted Biologics License 59 IND submission 59 Hepatitis C HCV 59 therapeutic monoclonal antibodies 59 histone deacetylase HDAC inhibitor 59 Vascular Closure Device 59 Preclinical Data 59 BioGlue R 59 Phase IIIb 59 Milestone Payment 59 cutaneous T 59 Clinical Trials Update 59 opioid induced bowel dysfunction 59 CEQ# 59 Biological Therapy 59 Single Dose 59 2 methoxyestradiol 59 FDA Orphan Drug 59 Investigational Device Exemption IDE 59 candidates bavituximab 59 ViaCyte 59 BrachySil 59 forodesine 59 Prodarsan ® 59 vitro diagnostic tests 59 Inflammatory Diseases 59 exemption IDE 59 factor VIIa 59 Aurexis